Successful tech transfer can be a challenge, even for well-established biotechs. Here’s how to avoid common pitfalls at every stage.
Modernized data governance ensures a solid foundation of data integrity and compliance and achieves an integrated approach to the BioPharma data lifecycle.
Speeding up time to insight throughout the BioPharma lifecycle requires all data sources to be connected and utilized to form a robust data backbone.
Life science companies rely on data integrity, security and transparency to ensure success. How do we protect data while keeping it accessible?
In the quest to develop the science and raise funding, developing a digital strategy in general is an afterthought for fledgling biotech companies – if it’s considered at all. Not paying attention to it early, however, can hamper their ability to advance their science and constrain their revenue-generation options.
A legacy system approach isn’t suitable for modern BioPharma development. Here are four reasons why.
Modern BioPharma development requires more than just a LIMS and spreadsheets. Learn why in this article by Alberto Pascual, IDBS, featuring Accenture and published in Lab Manager.
Compared to most other industries, life science and biopharmaceutical companies have been slow to embrace digital technologies. Why?
Life science companies need to harness the predictive value of data to drive deeper process understanding. Here’s how.
As the biopharmaceutical industry begins to embrace advanced data collection and analysis tools, it finds itself facing a challenging question: How can drug manufacturers best harness all that data to improve capacity, reduce bottlenecks and cut costs?
The pandemic exposed the innovation divide between the digitally transformed and those that lagged. Strict regulation made life sciences and BioPharma organizations hesitant to modernize too quickly away from proven legacy methods and technologies, resulting in varying levels of digital transformation. But are they missing out?
Wondering if an ELN can be used as a LIMS? Hear from IDBS and other experts in this interesting piece published in Lab Manager.